14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $31.48 Monday, 15th Apr 2024 AGIO stock ended at $29.26. This is 0.85% less than the trading day before Friday, 12th Apr 2024. During the day the stock fluctuated 3.72% from a day low at $28.73 to a day high of $29.80.
90 days $20.96 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
2024-04-15 $29.78 $29.80 $28.73 $29.26 617 987
2024-04-12 $30.50 $30.70 $28.71 $29.51 680 794
2024-04-11 $30.40 $31.02 $29.90 $30.63 801 382
2024-04-10 $29.23 $30.26 $29.05 $29.94 723 924
2024-04-09 $27.84 $29.86 $27.81 $29.71 941 579
2024-04-08 $27.56 $28.39 $27.14 $27.70 548 972
2024-04-05 $27.79 $28.24 $27.45 $27.55 550 054
2024-04-04 $28.81 $28.86 $27.72 $27.92 390 492
2024-04-03 $28.56 $28.73 $28.01 $28.47 514 742
2024-04-02 $28.38 $28.99 $27.91 $28.67 544 164
2024-04-01 $29.28 $29.37 $28.66 $28.86 401 480
2024-03-28 $29.19 $29.42 $28.82 $29.24 407 496
2024-03-27 $29.24 $29.42 $28.57 $29.12 647 397
2024-03-26 $30.07 $30.23 $28.87 $29.06 554 730
2024-03-25 $29.81 $30.21 $29.52 $29.68 413 837
2024-03-22 $30.40 $30.66 $29.84 $29.88 442 146
2024-03-21 $30.24 $31.48 $30.16 $30.24 532 677
2024-03-20 $29.93 $30.78 $29.75 $30.23 525 884
2024-03-19 $29.35 $30.39 $29.28 $30.09 544 618
2024-03-18 $29.88 $30.00 $28.94 $29.29 520 489
2024-03-15 $29.40 $30.33 $29.40 $29.94 1 186 888
2024-03-14 $29.82 $30.00 $29.02 $29.46 539 440
2024-03-13 $30.31 $30.96 $29.83 $30.00 517 270
2024-03-12 $30.74 $30.87 $30.02 $30.29 517 928
2024-03-11 $31.44 $31.77 $30.68 $30.80 407 572
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT